MDMA

Barn Raising For Shulgin Farm
Lykos, MAPS Cut Staff As New Leadership Takes Charge of MDMA-AT Research
Republican Congressman Jack Bergman Rallies Support For Psychedelic-Assisted Therapies
FDA Denies the Lykos Therapeutics Application for MDMA-Assisted Therapy
Lawmakers Express Bipartisan Support for MDMA-Assisted Therapy to Treat PTSD
MAPS Responds to FDA Advisors and Sets Future Goals
Lykos Offers New Measures for Additional Oversight if MDMA-AT Is Approved
How the FDA MDMA Decision Affects Therapists and Trainers
Can Lykos Therapeutics Address MDMA-AT Safety Concerns Ahead of FDA Decision?
How MAPS PBC Became Lykos Therapeutics and Raised $100M